Subsequent analysis using a publicly-available dataset revealed that the coordinated low-expression of CD163 and CXCR4 with high expression of THBS1 in 161 breast cancer tissues identified patients with TNBC (basal) having a high risk of recurrence and poor survival rate. The gene discussed is THBS1; the disease is breast carcinoma.